| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/15/2007 | WO2007018272A1 Sugar-modified liposome and composition for drug delivery containing the liposome |
| 02/15/2007 | WO2007018248A1 Pyridone compound |
| 02/15/2007 | WO2007018229A1 Treatment of adult t-cell leukemia |
| 02/15/2007 | WO2007018199A1 Cancer-rejection antigen peptide derived from glypican-3 (gpc3) for use in hal-a2-positive patient and pharmaceutical comprising the antigen |
| 02/15/2007 | WO2007018198A1 Cancer-rejection antigen peptide derived from hsp105 for use in hal-a2-positive patient and pharmaceutical comprising the antigen |
| 02/15/2007 | WO2007018147A1 Pharmaceutical titanium dioxide composite material of which pharmacological effect can be eliminated by light irradiation |
| 02/15/2007 | WO2007018143A1 Use of gene which varies in amount of expression during the course of transition from precancer to cancer |
| 02/15/2007 | WO2007018137A1 Multikinase inhibitor |
| 02/15/2007 | WO2007018049A1 Antigen capable of inducing neutralizing antibody for high risk-type human papillomavirus |
| 02/15/2007 | WO2007018047A1 Squamous cell carcinoma antigen-derived peptide binding to hla-a24 molecule |
| 02/15/2007 | WO2007017740A1 Salts and polymorphs of a vergf-r inhibitor |
| 02/15/2007 | WO2007017678A1 Pyrazolo[1,5-a] pyrimidine compounds and pharmaceutical compositions containing them |
| 02/15/2007 | WO2007017643A1 3 , llB-CIS-DIHYDROTETRABENAZINE FOR THE TREATMENT OF A PROLIFERATIVE DISEASE OR AN INFLAMMATION |
| 02/15/2007 | WO2007017585A2 Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 02/15/2007 | WO2007017577A1 7-substituted aza-indazoles, compositions containing same, production method and use thereof |
| 02/15/2007 | WO2007017507A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 02/15/2007 | WO2007017222A1 Pyrazole derivatives, their manufacture and their use as pharmaceutical agents |
| 02/15/2007 | WO2007017212A2 Use of an active biological substance in abnormal cellular and viral membrane physiologies |
| 02/15/2007 | WO2007017169A1 Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents |
| 02/15/2007 | WO2007017143A1 Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents |
| 02/15/2007 | WO2007017139A1 Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases |
| 02/15/2007 | WO2007017083A1 Pyrazole derivatives having tyrosinkinase activity |
| 02/15/2007 | WO2007017069A1 Adenine derivatives |
| 02/15/2007 | WO2007016979A2 NOVEL HETEROCYCLIC NF-κB INHIBITORS |
| 02/15/2007 | WO2007016954A1 Composition for reducing drug or alcohol induced breast cancer risk |
| 02/15/2007 | WO2007016777A1 Targeted protein kinase c inhibitors and uses thereof |
| 02/15/2007 | WO2006136837A3 Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators |
| 02/15/2007 | WO2006123122A3 Psk- i and its modulators for the treatment/diagnosis of cancer |
| 02/15/2007 | WO2006099095A3 Ribosome inhibitors as inhibitors of tyrosyl-dna-phosphodiesterase |
| 02/15/2007 | WO2006082304A3 Novel peptides which interact with anti-apoptotic members of the family of bcl-2 proteins and use thereof |
| 02/15/2007 | WO2006081337A3 Erastin analogues and their uses for killing cancer cells |
| 02/15/2007 | WO2006078752A3 Inhibitors of dna methyltransferase |
| 02/15/2007 | WO2006067614B1 Heteroaromatic derivatives useful as anticancer agents |
| 02/15/2007 | WO2006020060A3 Iap binding compounds |
| 02/15/2007 | WO2005110487A3 Camptothecin derivatives conjugated in position 20 with integrin antagonists |
| 02/15/2007 | US20070037996 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 02/15/2007 | US20070037995 A Substantially Cell Membrane Impermeable Compound And Use Thereof |
| 02/15/2007 | US20070037967 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer |
| 02/15/2007 | US20070037883 Therapeutic compositions |
| 02/15/2007 | US20070037879 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/15/2007 | US20070037878 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/15/2007 | US20070037864 Intermediates for the preparation of lipoxin A4 analogs |
| 02/15/2007 | US20070037856 Pyrrole-Type compounds, compositions and methods for treating cancer or viral disease |
| 02/15/2007 | US20070037852 Migrastatin analogs and uses thereof |
| 02/15/2007 | US20070037837 Quinazoline derivatives |
| 02/15/2007 | US20070037834 Bicyclic pyrimidine derivatives |
| 02/15/2007 | US20070037832 2-butylamino-8-hydroxy-9-(6-methyl-3-pyridylmethyl)adenine; interferon inducing activity; antiviral, antiallergic agent; immune response modulator; hepatitis B and C, asthma, atopic dermatitis |
| 02/15/2007 | US20070037826 Indolylmaleimide derivatives |
| 02/15/2007 | US20070037825 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 02/15/2007 | US20070037803 Benzimidazole derivatives |
| 02/15/2007 | US20070037774 Novel cytarabine monophosphate prodrugs |
| 02/15/2007 | US20070037770 Oligonucleotide N3'-P5' thiophosphoramidates: their synthesis and use |
| 02/15/2007 | US20070037750 Exendin agonist composed of a peptide in which at least one amino acid residue is acylated with a dicarboxylic acid; the amino acid residues are an internal lysine residue, an N-terminal amino acid residue, and/or a C-terminal amino acid residue; treatment of glucagonoma |
| 02/15/2007 | US20070037738 Using Inhibitors of Histone Deacetylases for the Suppression Therapy of Inherited Disease Predisposing Conditions |
| 02/15/2007 | US20070037159 Tetrahydrofolate synthetase gene |
| 02/15/2007 | US20070037147 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 02/15/2007 | US20070037145 drug screening; for carcinomas, especially lymphoma carcinomas |
| 02/15/2007 | US20070037136 Harvesting, separating, culturing and exposing tissue to antiproliferative agents, monitoring variation in tissue propagation; immunotherapeutics; wound healing agents |
| 02/15/2007 | US20070036854 Therapeutic applications of pro-apoptotic benzodiazepines |
| 02/15/2007 | US20070036812 polypeptide with binding to antigen and is recognized by cytotoxic T lymphocytes; use as cancer vaccine |
| 02/15/2007 | US20070036808 Cancer antigen peptide formulations |
| 02/15/2007 | US20070036798 Method and composition for reconforming multi-epitopic antigens to initiate an immune response |
| 02/15/2007 | US20070036790 Treatment with anti-vegf antibodies |
| 02/15/2007 | US20070036785 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
| 02/15/2007 | US20070036774 Liver engrafting cells, assays, and uses thereof |
| 02/15/2007 | US20070036759 Method of preparing a proliferation-regulated recombinant adenoviral vector efficiently and kit for preparing the same |
| 02/15/2007 | US20070036754 Treatment with anti-vegf antibodies |
| 02/15/2007 | US20070036753 Treatment with anti-vegf antibodies |
| 02/15/2007 | US20070036752 IL-2 fusion proteins with modulated selectivity |
| 02/15/2007 | US20070036751 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
| 02/15/2007 | US20070036720 Radiolabelled metal transport protein as imaging agent |
| 02/15/2007 | US20070036714 Porphyrin derivatives, methods for obtaining same, and use thereof in radioimmunotherapy |
| 02/15/2007 | DE202006017823U1 Dietic food with increased effect of free radical binder, useful, e.g. for the treatment of allergic condition disease, comprises a protein and a sugar |
| 02/15/2007 | DE102005038347A1 Herstellung einer Oxaliplatin-Lösung und Behälter sowie Behälter-Set mit der Lösung Producing an oxaliplatin solution and container and container set with the solution |
| 02/15/2007 | DE102005037733A1 Adeninderivate Adenine derivatives |
| 02/15/2007 | DE102005037499A1 Pyrazolderivate Pyrazole derivatives |
| 02/15/2007 | DE102005036656A1 Pharmaceutical composition containing IKK-beta inhibitor and agent for treating inflammation or tumor of the skin, useful for topical treatment of e.g. inflamed skin and tumors of the eye |
| 02/15/2007 | CA2820233A1 Perylenequinone derivatives and uses thereof |
| 02/15/2007 | CA2659961A1 Targeted protein kinase c inhibitors and uses thereof |
| 02/15/2007 | CA2620952A1 3, 11b-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation |
| 02/15/2007 | CA2619443A1 Glypican-3 (gpc3)-derived tumor rejection antigenic peptides useful for hla-a2-positive patients and pharmaceutical comprising the same |
| 02/15/2007 | CA2618765A1 Methods for treating b-cell malignancies using taci-ig fusion molecule |
| 02/15/2007 | CA2618763A1 Methods for the treatment and prevention of abnormal cell proliferation using taci-fusion molecules |
| 02/15/2007 | CA2618657A1 Method for evaluating compound using molecule on the rb pathway as index and molecular diagnostic method |
| 02/15/2007 | CA2618633A1 Adenine derivatives |
| 02/15/2007 | CA2618542A1 Prophylactic/therapeutic agent for cancer |
| 02/15/2007 | CA2618524A1 Pyrazole derivatives having tyrosine kinase activity |
| 02/15/2007 | CA2618370A1 Oxazolopyridine derivatives as sirtuin modulators |
| 02/15/2007 | CA2618360A1 Benzothiazoles and thiazolopyridines as sirtuin modulators |
| 02/15/2007 | CA2618112A1 Pyridone compound |
| 02/15/2007 | CA2618069A1 Dihydroxyanthraquinones and their use |
| 02/15/2007 | CA2618013A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 02/15/2007 | CA2617557A1 Benzimidazole derivatives as sirtuin modulators |
| 02/15/2007 | CA2617293A1 7-substituted aza-indazoles, compositions containing same, production method and use thereof |
| 02/15/2007 | CA2617274A1 Use of hdac inhibitors for the treatment of myeloma |
| 02/15/2007 | CA2617225A1 Novel heterocyclic nf-kb inhibitors |
| 02/15/2007 | CA2616075A1 Pyrazole derivatives, their manufacture and their use as pharmaceutical agents |
| 02/15/2007 | CA2615760A1 Salts and polymorphs of n,2-dimethyl-6-[7-(2-morpholinoethoxy)quinolin-4-yloxy]benzofuran-3-carboxamide |
| 02/15/2007 | CA2615695A1 Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents |